Document is current
Any future updates will be listed below
-
Authors
Pastor-Pascual, Francisco
Orts-Vila, Paz
Tañá-Sanz, Pedro
Tañá-Sanz, Santiago
Ruiz-Mesa, Ramón
Tañá-Rivero, Pedro
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00030579 at German Clinical Trials RegisterDocuments that mention this clinical trial
Non-diffractive, toric, extended depth-of-focus intraocular lenses in eyes with low corneal astigmatism
https://doi.org/10.1186/s40662-024-00380-7
-
Funding
Funding for this research was provided by:
Alcon (IIT#71895885)
- License Information
-
More Information
Article History
Received: 21 August 2023
Accepted: 7 March 2024
First Online: 1 April 2024
Declarations
:
: This study followed the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of the Hospital Clínico San Carlos (Madrid, Spain) and the Valencia Regional Committee of Observational Postmarketing Studies, CAEPRO (Valencia, Spain) (No. 22/304-O_P). All patients provided written informed consent before they were enrolled in the study. The study was registered with the German Clinical Trials Register (DRKS00030579).
: Not applicable.
: Francisco Pastor-Pascual participates in clinical studies for Alcon Laboratories, BVI, Carl Zeiss Meditec, Hoya and HumanOptics. Paz Orts-Vila participates in clinical studies for Alcon Laboratories, AST Products, BVI, Carl Zeiss Meditec, Hoya, HumanOptics and Johnson&Johnson. Ramón Ruiz-Mesa participates in clinical studies for Alcon Laboratories, Bausch&Lomb, Biotech, Carl Zeiss Meditec, Cristalens, Hoya, Medicontur and Sifi. Pedro Tañá-Rivero participates in clinical studies for Alcon Laboratories, AST Products, BVI, Carl Zeiss Meditec, Hoya, HumanOptics and Johnson&Johnson. The authors have no financial or proprietary interest in any product, method or material described herein.
